These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25744617)

  • 1. Long-term survival with growth hormone replacement after liver transplantation of pediatric nonalcoholic steatohepatitis complicating acquired hypopituitarism.
    Fujio A; Kawagishi N; Echizenya T; Tokodai K; Nakanishi C; Miyagi S; Sato K; Fujimori K; Ohuchi N
    Tohoku J Exp Med; 2015 Jan; 235(1):61-7. PubMed ID: 25744617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric nonalcoholic steatohepatitis associated with hypopituitarism.
    Nakajima K; Hashimoto E; Kaneda H; Tokushige K; Shiratori K; Hizuka N; Takano K
    J Gastroenterol; 2005 Mar; 40(3):312-5. PubMed ID: 15830293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolution of non-alcoholic steatohepatitis after growth hormone replacement in a pediatric liver transplant patient with panhypopituitarism.
    Gilliland T; Dufour S; Shulman GI; Petersen KF; Emre SH
    Pediatr Transplant; 2016 Dec; 20(8):1157-1163. PubMed ID: 27762491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone-replacement Therapy for Hepatopulmonary Syndrome and NASH Associated with Hypopituitarism.
    Torii N; Ichihara A; Mizuguchi Y; Seki Y; Hashimoto E; Tokushige K
    Intern Med; 2018; 57(12):1741-1745. PubMed ID: 29910217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of growth hormone replacement therapy on liver function in adult patients with growth hormone deficiency.
    Matsumoto R; Fukuoka H; Iguchi G; Nishizawa H; Bando H; Suda K; Takahashi M; Takahashi Y
    Growth Horm IGF Res; 2014 Oct; 24(5):174-9. PubMed ID: 25116471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation.
    Sourianarayanane A; Arikapudi S; McCullough AJ; Humar A
    Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):481-487. PubMed ID: 28253211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and risk factors for recurrence of nonalcoholic steatohepatitis following liver transplantation.
    Tokodai K; Karadagi A; Kjaernet F; Romano A; Ericzon BG; Nowak G
    Scand J Gastroenterol; 2019 Feb; 54(2):233-239. PubMed ID: 30999770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of non-alcoholic steatohepatitis after liver transplantation in a 13-yr-old boy.
    Jankowska I; Socha P; Pawlowska J; Teisseyre M; Gliwicz D; Czubkowski P; Kalicinski P; Cielecka-Kuszyk J; Socha J
    Pediatr Transplant; 2007 Nov; 11(7):796-8. PubMed ID: 17910660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
    Mikolasevic I; Filipec-Kanizaj T; Mijic M; Jakopcic I; Milic S; Hrstic I; Sobocan N; Stimac D; Burra P
    World J Gastroenterol; 2018 Apr; 24(14):1491-1506. PubMed ID: 29662288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis-Related Cirrhosis.
    Bhati C; Idowu MO; Sanyal AJ; Rivera M; Driscoll C; Stravitz RT; Kohli DR; Matherly S; Puri P; Gilles H; Cotterell A; Levy M; Sterling RK; Luketic VA; Lee H; Sharma A; Siddiqui MS
    Transplantation; 2017 Aug; 101(8):1867-1874. PubMed ID: 28296807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control study.
    Unger LW; Herac M; Staufer K; Salat A; Silberhumer G; Hofmann M; Trauner M; Rasoul-Rockenschaub S; Soliman T; Reiberger T; Berlakovich GA
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):309-316. PubMed ID: 27922486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.
    Angulo P; Kleiner DE; Dam-Larsen S; Adams LA; Bjornsson ES; Charatcharoenwitthaya P; Mills PR; Keach JC; Lafferty HD; Stahler A; Haflidadottir S; Bendtsen F
    Gastroenterology; 2015 Aug; 149(2):389-97.e10. PubMed ID: 25935633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid recurrence of nonalcoholic fatty liver disease after transplantation in a child with hypopituitarism and hepatopulmonary syndrome.
    Jonas MM; Krawczuk LE; Kim HB; Lillehei C; Perez-Atayde A
    Liver Transpl; 2005 Jan; 11(1):108-10. PubMed ID: 15690545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
    Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M
    Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation and non-alcoholic fatty liver disease.
    Zezos P; Renner EL
    World J Gastroenterol; 2014 Nov; 20(42):15532-8. PubMed ID: 25400437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation for nonalcoholic steatohepatitis in young patients.
    Alkhouri N; Hanouneh IA; Zein NN; Lopez R; Kelly D; Eghtesad B; Fung JJ
    Transpl Int; 2016 Apr; 29(4):418-24. PubMed ID: 26402655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Fukusato T
    World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction.
    Adams LA; Feldstein A; Lindor KD; Angulo P
    Hepatology; 2004 Apr; 39(4):909-14. PubMed ID: 15057893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis.
    Saeed N; Glass L; Sharma P; Shannon C; Sonnenday CJ; Tincopa MA
    Transplantation; 2019 Nov; 103(11):e345-e354. PubMed ID: 31415032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of anti-receptor activator of nuclear factor-kappa B ligand (RANKL) antibody for the treatment of osteoporosis was associated with amelioration of hepatitis in a female patient with growth hormone deficiency: a case report.
    Takeno A; Yamamoto M; Notsu M; Sugimoto T
    BMC Endocr Disord; 2016 Nov; 16(1):66. PubMed ID: 27881164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.